A Blesl
Overview
Explore the profile of A Blesl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
Lenti M, Ribaldone D, Borrelli de Andreis F, Vernero M, Barberio B, De Ruvo M, et al.
ESMO Open
. 2024 Jul;
9(7):103632.
PMID: 38970840
Background: Data regarding the clinical outcome of patients with immune checkpoint inhibitor (ICI)-induced colitis are scant. We aimed to describe the 12-month clinical outcome of patients with ICI-induced colitis. Materials...
2.
Stadlbauer V, Horvath A, Komarova I, Schmerboeck B, Feldbacher N, Klymiuk I, et al.
Benef Microbes
. 2019 Jan;
10(3):265-278.
PMID: 30694100
The gut is hypothesised to play an important role in the development and progression of sepsis. It is however unknown whether the gut microbiome and the gut barrier function is...
3.
Rainer F, Horvath A, Sandahl T, Leber B, Schmerboeck B, Blesl A, et al.
Aliment Pharmacol Ther
. 2017 Dec;
47(5):657-664.
PMID: 29266346
Background: Activated hepatic macrophages play a key role in inflammation and fibrosis progression in chronic liver disease. Aim: To assess the prognostic value of soluble (s)CD163 and mannose receptor (sMR)...
4.
Bilgilier C, Stadlmann A, Makristathis A, Thannesberger J, Kastner M, Knoflach P, et al.
Clin Microbiol Infect
. 2017 Jul;
24(3):267-272.
PMID: 28669844
Objectives: We report on a large prospective, multicentre clinical investigation on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. Methods: Therapy-naive patients (n = 2004) who had...